Immune Regulation Research
Kingston Mills BA (Mod), PhD
Kingston Mills is Professor of Experimental Immunology, School of Biochemistry and Immunology, Trinity College Dublin (TCD). He is Head of The Centre for the Study of Immunology at Trinity Biomedical Sciences Institute and Theme Champion for Immunology, Inflammation and Infection at TCD.
Kingston Mills is a Co-founder and former Director of the spin-off campus company, Opsona Therapeutics Ltd, involved in the development and clinical evaluation of immunotherapeutics to treat autoimmune and chronic inflammatory conditions.
Kingston Mills is a Co-founder, Chief Scientific Officer of the spin-off campus company, TriMod Therapeutics Ltd, involved in the development immunotherapeutics and vaccine to treat cancer.
IMMUNOLOGY RESEARCH CENTRE
The Immunology Research Centre in TCD is Academic-Industry partnership funded by a Strategic Research Cluster award from Science Foundation Ireland (SFI). This €10m 5-year research programme is lead by Trinity College Dublin in collaboration with NUI Maynooth. The research is focused on the discovery and function of novel exogenous, endogenous and synthetic modulators (activators and inhibitors) of innate immunity. This is an integrated collaborative project involving 8 PIs at TCD, Prof Kingston Mills (Director) Prof Luke O'Neill, Prof Seamus Martin, Prof Dermot Kelleher, Prof Andrew Bowie, Dr Joe Keane, Dr Clair Gardiner and Prof Ed Lavelle and Prof Paul Moynagh at NUI Maynooth.
Our research focuses on the following areas:
- Manipulating the balance between regulatory and effector/pathogenic T cells - implications for disease processes (SFI project).
- Pathogen Modulation of Immune Responses
- Immunity to Infectious Diseases and Vaccines
- Tumor Immunology